Read + Share
Oikawa Y, Izumi R, Koide M, Hagiwara Y, et al. Mitochondrial dysfunction underlying sporadic inclusion body myositis is
ameliorated by the mitochondrial homing drug MA-5. PLoS One 2020;15:e0231064.
PMID: 33264289
|
 |
|
Oikawa Y, Izumi R, Koide M, Hagiwara Y, et al. Mitochondrial dysfunction underlying sporadic inclusion body myositis is
ameliorated by the mitochondrial homing drug MA-5. PLoS One 2020;15:e0231064.
PMID: 33264289
|
|
|
|